Clinical Trial Update: HEAT Trial (HER2 Antibody Therapy With Lutetium-177) [EARLY_Phase 1]

View source ↗

Summary

This update announces that the HEAT trial, a Phase 1 study of a HER2-targeted antibody therapy with Lutetium-177, is currently recruiting for advanced solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• HEAT investigational therapy (HER2 antibody therapy with Lutetium-177) (HER2-targeted antibody radiopharmaceutical with Lutetium-177)

Snippet

Sponsor: Radiopharm Theranostics, Ltd | Conditions: HER2 Gene Mutation, Advanced Solid Tumors | EARLY_Phase 1 | Status: RECRUITING